Form 144 TEVA PHARMACEUTICAL INDUSTRIES LTD For: 4 May

Vanda launches motion sickness drug after 40-year gap

Investing.com · News 5m ago

BMO reiterates FMC stock rating on 2026 guidance, asset sale plans

Investing.com · News 5m ago

Devil Wears Prada 2 opens with $77M at domestic box office

Investing.com · News 5m ago

BMO Capital reiterates Bristol-Myers Squibb stock rating at Market Perform

Investing.com · News 6m ago

American Express Global Business Travel Enters $6.3 Billion Take-Private Deal

Dow Jones · Markets 6m ago

Stifel reiterates Klaviyo stock rating on platform evolution

Investing.com · News 6m ago

HSBC lowers AMD to Hold ahead of earnings on limited upside potential

Investing.com · Investing_news 9m ago

EagleRock Land seeks to raise $346 million in US IPO

Investing.com · News 16m ago

Two Harbors rejects revised UWMC bid, backs CrossCountry deal

Investing.com · News 16m ago

Stifel cuts Whirlpool stock price target on cost pressures

Investing.com · News 17m ago